药物补充模型在美国的特征. 门诊护理:对计划类型,障碍和促进者的全面审查
Ana L Hincapie1, Elizabeth Schlosser1, Lauren Auteri2
1Department of Pharmacy Practice and Administrative Sicences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH; Ambulatory Care Pharmacy, St. Elizabeth Physicians, Hebron, KY.
Journal of the American Pharmacists Association : JAPhA
|October 16, 2025
概括
美国门诊护理中的药物补充计划各不相同,确定了单个办公室和集中式模式. 药剂师是关键,但角色谈判可能是一个障碍.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 药房实践 在药房实践中
- 健行护理服务提供者
背景情况:
- 处方补充授权计划提高了门诊护理的效率.
- 关于这些计划的特点和结果的证据有限.
- 本综述解决了有关美国门诊护理中药物补充计划的知识差距.
研究的目的:
- 描述美国门诊护理中药物补充计划的特点和结果.
- 确定影响这些计划实施的障碍和促进者.
主要方法:
- 根据乔安娜·布里格斯研究所 (JBI) 的指导方针进行范围审查.
- 搜索了PubMed,Embase,CINHAL,科学网,以及灰色文学 (2010年至2025年3月).
- 包括美国门诊护理药物补充计划的研究;定性数据以主题分析.
主要成果:
- 包括25项研究,确定了两个主要的补充模式:单一办公室和集中式.
- 集中式模型具有高度的自动化,并为多个临床办公室提供服务.
- 处方补充量是一个常见的结果;七个主题出现了障碍和促进者.
结论:
- 美国的门诊护理机构使用各种药物补充模型,经常利用电子医疗记录.
- 药剂师是大多数计划的核心,对于药物管理至关重要.
- 障碍包括专业角色谈判,而促进者包括自动协议和集中.
相关概念视频
Methods of Documentation VI: Case Management Model
854
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
854
Clearance Models: Compartment Models
300
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
300
Clearance Models: Noncompartmental Models
240
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
240
Three-Compartment Open Model
839
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
839
Pharmacokinetic Models: Overview
1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Model Approaches for Pharmacokinetic Data: Compartment Models
524
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
524


